Hemodynamic Studies in a Case of Carcinoid Cardiovascular Syndrome
- 1 August 1959
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 20 (2) , 208-214
- https://doi.org/10.1161/01.cir.20.2.208
Abstract
A case of malignant carcinoid metastatic to the liver with the typical features of the carcinoid cardiovascular syndrome has been presented. Hemodynamic data obtained at cardiac catheterization indicated the presence of tricuspid insufficiency, low cardiac output, and slight pulmonary hypertension. Unilateral pulmonary artery occlusion studies were reported that suggest the absence of intrinsic pulmonary vascular disease in this syndrome. The paradox of infrequent instances of significant pulmonary hypertension in the presence of serotonin in the reported cases of carcinoid cardiovascular syndrome was discussed. The effect of reserpine on pulmonary artery pressure was reported.Keywords
This publication has 8 references indexed in Scilit:
- Carcinoid syndrome produced by metastasizing bronchial adenomaThe American Journal of Medicine, 1958
- Pulmonary and Systemic Vascular Response to Continuous Infusion of 5-Hydroxytryptamine (Serotonin) in the DogAmerican Journal of Physiology-Legacy Content, 1957
- A clinical, physiologic and biochemical study of patients with malignant carcinoid (argentaffinoma)The American Journal of Medicine, 1956
- Antagonism of 5-Hydroxytryptamine by ChlorpromazineScience, 1956
- CARCINOID CARDIOVASCULAR DISEASE1956
- Serotonin Release as a Possible Mechanism of Reserpine ActionScience, 1955
- YOHIMBINE AND ERGOT ALKALOIDS AS NATURALLY OCCURRING ANTIMETABOLITES OF SEROTONINJournal of Biological Chemistry, 1953
- Nature of the Lung Enzyme which inactivates Serum VasoconstrictorNature, 1950